We are live on ! Find out more
MIM

MetLife Investment Management Portfolio holdings

AUM $19.6B
1-Year Est. Return 32.64%
This Fund
S&P 500
This Quarter Est. Return
+13.04%
1 Year Est. Return
+32.64%
3 Year Est. Return
+107.14%
5 Year Est. Return
+140.16%
10 Year Est. Return
AUM
$13.9B
AUM Growth
+$1.06B
Cap. Flow
-$389M
Cap. Flow %
-2.8%
Top 10 Hldgs %
25.44%
Holding
2,969
New
81
Increased
186
Reduced
1,131
Closed
145

Top Buys

Rank Stock Value
1
ACN icon
Accenture
ACN
+$57.5M
2
MDT icon
Medtronic
MDT
+$24.4M
3
UBER icon
Uber
UBER
+$24M
4
AON icon
Aon
AON
+$15.5M
5
TT icon
Trane Technologies
TT
+$12.6M

Sector Composition

Rank Sector Weight
1 Technology 27.1%
2 Financials 12.28%
3 Healthcare 11.96%
4 Consumer Discretionary 11.51%
5 Industrials 9.52%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake
Capital Flow
RTX icon
76
RTX Corp
RTX
$300B
$29.4M 0.21%
349,071
-11,066
-3% -$876K
T icon
77
AT&T
T
$166B
$29.1M 0.21%
1,735,945
-32,583
-2% -$514K
LRCX icon
78
Lam Research
LRCX
$408B
$29.1M 0.21%
371,290
-11,540
-3% -$786K
UPS icon
79
United Parcel Service
UPS
$88.4B
$28.9M 0.21%
183,864
-3,416
-2% -$516K
AMT icon
80
American Tower
AMT
$79.4B
$28.6M 0.21%
132,341
-2,350
-2% -$444K
MS icon
81
Morgan Stanley
MS
$342B
$28.5M 0.21%
305,606
-8,518
-3% -$681K
LMT icon
82
Lockheed Martin
LMT
$140B
$28.4M 0.2%
62,750
-2,153
-3% -$954K
BLK icon
83
Blackrock
BLK
$180B
$27.7M 0.2%
34,121
-761
-2% -$531K
AXP icon
84
American Express
AXP
$232B
$27.7M 0.2%
147,687
-4,503
-3% -$725K
ELV icon
85
Elevance Health
ELV
$86.6B
$27.5M 0.2%
58,381
-1,250
-2% -$578K
ADP icon
86
Automatic Data Processing
ADP
$107B
$26.7M 0.19%
114,519
-2,205
-2% -$514K
MDT icon
87
Medtronic
MDT
$116B
$26.6M 0.19%
322,958
+319,981
+10,748% +$24.4M
BX icon
88
Blackstone
BX
$110B
$26.4M 0.19%
201,897
-3,409
-2% -$369K
PANW icon
89
Palo Alto Networks
PANW
$315B
$25.9M 0.19%
175,386
-864
-0.5% -$116K
SYK icon
90
Stryker
SYK
$133B
$25.8M 0.19%
86,132
-1,577
-2% -$443K
MRSH
91
Marsh
MRSH
$90.1B
$25.8M 0.19%
136,075
-2,646
-2% -$511K
ZTS icon
92
Zoetis
ZTS
$30.4B
$25.8M 0.19%
130,603
-2,594
-2% -$459K
PGR icon
93
Progressive
PGR
$121B
$25.5M 0.18%
160,052
-2,953
-2% -$462K
BMY icon
94
Bristol-Myers Squibb
BMY
$130B
$25.3M 0.18%
493,989
-23,014
-4% -$1.21M
MDY icon
95
State Street SPDR S&P MIDCAP 400 ETF Trust
MDY
$27.2B
$25.2M 0.18%
49,700
-4,200
-8% -$1.95M
SCHW
96
Charles Schwab
SCHW
$189B
$24.8M 0.18%
361,163
-6,548
-2% -$378K
CVS icon
97
CVS Health
CVS
$121B
$24.6M 0.18%
311,726
-5,893
-2% -$419K
GILD icon
98
Gilead Sciences
GILD
$168B
$24.5M 0.18%
302,565
-5,714
-2% -$445K
ADI icon
99
Analog Devices
ADI
$187B
$24M 0.17%
120,964
-3,143
-3% -$561K
MDLZ icon
100
Mondelez International
MDLZ
$79.4B
$23.9M 0.17%
330,248
-6,240
-2% -$428K

Similar funds

MetLife Investment Management's Q4 2023 Portfolio in Review

As of Q4 2023, MetLife Investment Management held 2,969 positions worth $13.9B, up 8.2% from $12.8B the previous quarter. Its ten largest holdings account for 25% of the portfolio.

MetLife Investment Management's Q4 2023 filing shows 81 new, 186 increased, 1,131 reduced and 145 closed positions. Its largest new stake was Accenture: 178,487 shares worth $62.6M. The largest sale was State Street SPDR S&P 500 ETF Trust, an estimated $81.9M.

By sector, the portfolio is most concentrated in Technology at 27% of assets, up from 25% a quarter earlier, followed by Financials and Healthcare.

  • MetLife Investment Management's largest Q4 2023 buy was Accenture: 178,487 shares worth $62.6M.
  • MetLife Investment Management added most to Medtronic in Q4 2023, an estimated $24.4M increase.
  • MetLife Investment Management's biggest Q4 2023 reduction was State Street SPDR S&P 500 ETF Trust, cutting an estimated $81.9M.
  • MetLife Investment Management fully exited iShares Core US Aggregate Bond ETF in Q4 2023, selling an estimated $40.8M.
  • MetLife Investment Management's ten largest holdings make up 25% of its $13.9B portfolio in Q4 2023.
  • MetLife Investment Management opened 81 new positions and closed 145 in Q4 2023.
  • MetLife Investment Management's portfolio value rose 8.2% quarter-over-quarter to $13.9B.

Based on MetLife Investment Management's 13F filing for Q4 2023, filed 14 Feb 2024.